Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Transine Therapeutics
Transine Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Transine Therapeutics
Total Funding
$12.6 M
Transine Therapeutics Summary
Company Summary
Overview
Transine Therapeutics is a developer of biotech platform that specializes in research of therapeutic RNAs. Its technology is expected to offer a mechanism of action for currently hard-to-treat diseases.
Type
Private
Status
Active
Founded
2020
HQ
Babraham, GB
|
view all locations
Website
https://www.transinetx.com/
Cybersecurity rating
Sectors
Technology
biotech
clinical research
medical diagnostics
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Jan Thirkettle,
CEO
Linkedin
Sarah L. Cole,
VP of R & D and Operations
Linkedin
Emmanuelle Astoul,
Head of Licensing
Linkedin
Michael Jones,
Founder Director
and 2 others
Locations
View all
1 location detected
Babraham, England
HQ
United Kingdom
Babraham Hall House
Competitors and Similar Companies
WuXi Diagnostics
Technology - Private
XCyton
Technology - Private
TwistDx
Technology - Private
SpeeDx
Technology - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top